TABLE 1.

Baseline subject demographic characteristics.

Characteristics	Keverprazan 20 mg	Keverprazan 40 mg	Vonoprazan 20 mg	Placebo
N	8	8	4	6
Age, years	22.63 ± 4.17	28.88 ± 4.22	26.00 ± 4.08	30.67 ± 2.07
Gender, male	4 (50.0%)	4 (50.0%)	2 (50.0%)	2 (33.3%)
Height, cm	167.15 ± 6.81	165.20 ± 7.09	165.03 ± 10.92	166.27 ± 11.63
Weight, kg	64.57 ± 7.51	60.18 ± 7.59	60.50 ± 9.13	60.18 ± 8.85
BMI, kg/m2	23.10 ± 2.28	22.04 ± 2.28	22.12 ± 1.12	21.70 ± 1.43
Surgical history	0	2 (25.0%)	0	2 (33.3%)

Abbreviation: BMI, body mass index.